Press Releases

Data Presented at ADA Show the Effects of GI Dynamics’ EndoBarrier® Therapy on Glycemic Control and Reducing Diabetes Medication in Patients with Type 2 Diabetes and Obesity

Data Presented at the Scientific Sessions of the American Diabetes Association Demonstrate Increased Bile Acids Levels Following EndoBarrier Therapy; Further Establishes Potential Mechanism of Action SAN FRANCISCO, United States and SYDNEY, Australia – 16 June 2014 – GI Dynamics, Inc. (ASX: GID),...

read more

Appendix 4C Quarterly Report Quarter ended 31 March 2014

GI Dynamics to Hold Briefing Call and Webcast on Financial Results  for First Quarter 2014 on Tuesday, 29 April 2014 at 6 p.m. U.S. EDT  and Wednesday, 30 April 2014 at 8:00 a.m. AEST   LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 29 April 2014 – GI Dynamics, Inc. (ASX: GID) (GI...

read more
Page 8 of 18« First...678910...Last »